Published in Int J Colorectal Dis on June 11, 2005
Crohn's disease complicated by strictures: a systematic review. Gut (2013) 1.46
Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease. Can J Gastroenterol (2009) 1.06
Anti-fibrogenic effects of the anti-microbial peptide cathelicidin in murine colitis-associated fibrosis. Cell Mol Gastroenterol Hepatol (2015) 1.00
A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora. Gut (2009) 1.00
Mechanisms, Management, and Treatment of Fibrosis in Patients with Inflammatory Bowel Diseases. Gastroenterology (2016) 0.83
Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin? World J Gastrointest Pathophysiol (2013) 0.80
Serial intralesional injections of infliximab in small bowel Crohn's strictures are feasible and might lower inflammation. United European Gastroenterol J (2014) 0.79
Altered molecular pattern of mucosal healing in Crohn's disease fibrotic stenosis. World J Gastrointest Pathophysiol (2013) 0.78
Potent suppression of arginase 1 expression in murine macrophages by low dose endotoxin. Am J Clin Exp Immunol (2013) 0.78
Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD. United European Gastroenterol J (2016) 0.76
Multidisciplinary management of gastrointestinal fibrotic stenosis in Crohn's disease. Dig Dis Sci (2014) 0.75
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med (1997) 10.67
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology (1995) 4.39
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology (2004) 4.26
The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology (2004) 3.50
Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet (2004) 3.19
Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial. Gastroenterology (1999) 2.80
Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology (2002) 2.66
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. Gastroenterology (1999) 2.62
Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology (1999) 2.46
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology (2002) 2.15
Collagen content and types in the intestinal strictures of Crohn's disease. Gastroenterology (1988) 1.77
Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models. Am J Physiol Gastrointest Liver Physiol (2000) 1.43
Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation. Gut (1990) 1.24
Medical therapy for Crohn's disease strictures. Inflamm Bowel Dis (2004) 1.18
Benign and malignant colorectal strictures in ulcerative colitis. Gut (1992) 1.13
Transmembrane TNF-alpha, induction of apoptosis, and the efficacy of TNF-targeting therapies in Crohn's disease. Gastroenterology (2001) 1.01
IGF-I induces collagen and IGFBP-5 mRNA in rat intestinal smooth muscle. Am J Physiol (1997) 1.01
Cytokines and inflammatory bowel disease. Baillieres Clin Gastroenterol (1996) 0.97
Inflammatory bowel disease. Aliment Pharmacol Ther (2003) 0.94
Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003. Int J Colorectal Dis (2001) 0.94
Cytokines increase proliferation of human intestinal smooth muscle cells: possible role in inflammation-induced stricture formation. Inflammation (1993) 0.89
Endoscopic treatment of stenosis in recurrent Crohn's disease with balloon dilation combined with local corticosteroid injection. Gastrointest Endosc (1995) 0.89
Review article: maintenance treatment of Crohn's disease. Aliment Pharmacol Ther (2003) 0.87
Contribution of morphology for the comprehension of mechanisms of fibrosis in inflammatory enterocolitis. Acta Gastroenterol Belg (2001) 0.86
Can we influence fibrosis in Crohn's disease? Acta Gastroenterol Belg (2001) 0.77
Mechanisms of infliximab: the reverse side of a drug effect. Inflamm Bowel Dis (2004) 0.76
Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease. Clin Gastroenterol Hepatol (2010) 2.79
Unexpected expression of alpha- and beta-globin in mesencephalic dopaminergic neurons and glial cells. Proc Natl Acad Sci U S A (2009) 1.64
User attitudes in analyzing digital slides in a quality control test bed: a preliminary study. Comput Methods Programs Biomed (2006) 1.57
Colonic sarcoidosis, infliximab, and tuberculosis: a cautionary tale. Inflamm Bowel Dis (2004) 1.51
Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. Arch Intern Med (2007) 1.51
Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: partial benefit by infliximab--a pilot study. Dig Dis Sci (2012) 1.50
Digital storage of glass slides for quality assurance in histopathology and cytopathology. J Telemed Telecare (2002) 1.23
Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J Clin Endocrinol Metab (2006) 1.23
Multipotent progenitor cells are present in human peripheral blood. Circ Res (2009) 1.20
Subcellular localization of APE1/Ref-1 in human hepatocellular carcinoma: possible prognostic significance. Mol Med (2007) 1.17
Piecemeal degranulation as a general secretory mechanism? Anat Rec A Discov Mol Cell Evol Biol (2003) 1.09
Prognostic role of Ape/Ref-1 subcellular expression in stage I-III breast carcinomas. Oncol Rep (2001) 1.08
Malignant granular cell tumor of the anal-perianal region and suprarenal hyperplasia: a casual association? Indian J Dermatol (2010) 1.01
Reliability and reproducibility of the edmondson grading of hepatocellular carcinoma using paired core biopsy and surgical resection specimens. Arch Pathol Lab Med (2010) 0.97
Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas. Stem Cells (2014) 0.97
Proteomic analysis of liver tissues subjected to early ischemia/reperfusion injury during human orthotopic liver transplantation. Proteomics (2006) 0.95
Steatosis of the hepatic graft as a risk factor for post-transplant biliary complications. Clin Transplant (2010) 0.93
Portal vein thrombosis after intraportal hepatocytes transplantation in a liver transplant recipient. Transpl Int (2005) 0.93
Differential proteomic analysis of hepatocellular carcinoma. Int J Oncol (2010) 0.92
Comparison of portal venous and delayed phases of gadolinium-enhanced magnetic resonance imaging study of cirrhotic liver for the detection of contrast washout of hypervascular hepatocellular carcinoma. J Comput Assist Tomogr (2010) 0.92
Adrenal angiosarcoma: report of a case. Surg Today (2002) 0.91
Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation. J Gastroenterol Hepatol (2007) 0.91
TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer. Cytokine (2008) 0.91
Pluripotency rush! Molecular cues for pluripotency, genetic reprogramming of adult stem cells, and widely multipotent adult cells. Pharmacol Ther (2009) 0.91
MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption. Alcohol Clin Exp Res (2008) 0.90
Adipose tissue-derived stem cell in vitro differentiation in a three-dimensional dental bud structure. Am J Pathol (2011) 0.90
Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma. Transpl Int (2007) 0.89
Dental pulp stem cells differentiation reveals new insights in Oct4A dynamics. PLoS One (2012) 0.89
A human neuronal model of Niemann Pick C disease developed from stem cells isolated from patient's skin. Orphanet J Rare Dis (2013) 0.88
Circulating stem cell vary with NYHA stage in heart failure patients. J Cell Mol Med (2011) 0.88
Ex vivo molecular rejuvenation improves the therapeutic activity of senescent human cardiac stem cells in a mouse model of myocardial infarction. Stem Cells (2014) 0.87
MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's disease of the terminal ileum. Acad Radiol (2008) 0.87
Elevated serum CA 19-9 in hepatic actinomycosis. Scand J Gastroenterol (2005) 0.86
Role of tumor associated fibroblasts in human liver regeneration, cirrhosis, and cancer. Int J Hepatol (2011) 0.86
Tamoxifen and its main metabolites serum and tissue concentrations in breast cancer women. Ther Drug Monit (2007) 0.85
Absolute quantification of choline-related biomarkers in breast cancer biopsies by liquid chromatography electrospray ionization mass spectrometry. Anal Cell Pathol (Amst) (2013) 0.85
Neuropathological and clinical phenotype of an Italian Alzheimer family with M239V mutation of presenilin 2 gene. J Neuropathol Exp Neurol (2004) 0.85
Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma. Tumour Biol (2012) 0.85
Partitioning of bronchopulmonary carcinoids in two different prognostic categories by ki-67 score. Front Endocrinol (Lausanne) (2011) 0.84
Human adipose-derived stem cells for the treatment of chemically burned rat cornea: preliminary results. Curr Eye Res (2013) 0.84
A survey on non specialized off-the-shelf JPEG2000 viewers for digital microscopy use. Diagn Pathol (2008) 0.84
Biochemical and biophysical analyses of tissue-engineered bone obtained from three-dimensional culture of a subset of bone marrow mesenchymal stem cells. Tissue Eng Part A (2010) 0.84
Helicobacter pylori associated antigastric autoantibodies: role in Sjögren's syndrome gastritis. Helicobacter (2004) 0.83
Carriage of the apolipoprotein E-epsilon4 allele and histologic outcome of recurrent hepatitis C after antiviral treatment. Am J Clin Pathol (2004) 0.82
Survivin, MMP-2, MT1-MMP, and TIMP-2: their impact on survival, implantation, and proliferation of endometriotic tissues. Virchows Arch (2012) 0.82
Annular elastolytic giant cell granuloma treated with topical pimecrolimus. Indian J Dermatol Venereol Leprol (2014) 0.82
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts. Histopathology (2009) 0.81
Mesenchymal chondrosarcoma of the spleen: report of a case. Tumori (2011) 0.81
Is water diffusion isotropic in the cirrhotic liver? a study with diffusion-weighted imaging at 3.0 Tesla. Acad Radiol (2011) 0.81
Number of pericryptal fibroblasts correlates with density of distinct mast cell phenotypes in the crypt lamina propria of human duodenum: implications for the homeostasis of villous architecture. Anat Rec A Discov Mol Cell Evol Biol (2006) 0.81
Prevention of postoperative recurrence of Crohn's disease by infliximab. Eur J Gastroenterol Hepatol (2006) 0.81
A KIT-negative, DOG1-positive epithelioid GIST of the stomach harboring a novel PDGFRA exon 14 single nucleotide deletion. Anticancer Res (2012) 0.80
Selective heparanase localization in malignant melanoma. Int J Oncol (2005) 0.80
The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo Osseo. Hum Pathol (2010) 0.80
Arterial rupture as the result of fungal arteritis after renal transplantation. Transplantation (2003) 0.80
TNF-alpha modulates the migratory response of mesenchymal stem cells to TRAIL. Cell Mol Life Sci (2010) 0.80
Expression patterns of Aurora A and B kinases, Ki-67 and the estrogen and progesterone receptors determined using an endometriosis tissue microarray model. Hum Reprod (2011) 0.80
Pegylated versus standard interferon-alpha in antiviral regimens for post-transplant recurrent hepatitis C: Comparison of tolerability and efficacy. J Gastroenterol Hepatol (2005) 0.80
Granule changes of human and murine endocrine cells in the gastrointestinal epithelia are characteristic of piecemeal degranulation. Anat Rec (2002) 0.80
Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma. Open Rheumatol J (2008) 0.79
Piecemeal degranulation in human tumour pheochromocytes. J Anat (2005) 0.79
Acellular bone colonization and aggregate culture conditions diversely influence murine periosteum mesenchymal stem cell differentiation potential in long-term in vitro osteoinductive conditions. Tissue Eng Part A (2012) 0.79
Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression. Clin Transplant (2009) 0.79
Hepatocyte growth factor and transforming growth factor beta1 ratio at baseline can predict early response to cyclophosphamide in systemic lupus erythematosus nephritis. Arthritis Rheum (2006) 0.79
At the stem of youth and health. Pharmacol Ther (2010) 0.79
Fibrotic strictures and anti-TNF-alpha therapy in Crohn's disease. Digestion (2007) 0.79
The mast cell: a multifunctional effector cell. Adv Clin Path (2003) 0.78
Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor used. Transplantation (2012) 0.78
Celiac disease and intestinal metaplasia of the esophagus (Barrett's esophagus). Dig Dis Sci (2005) 0.78
Role of oral cyclophosphamide in the treatment of giant cell arteritis. Rheumatology (Oxford) (2012) 0.78
Instrumental clinical restaging, pathological evaluation, and tumor regression grading: how to assess the response to neoadjuvant chemoradiotherapy for rectal cancer. Int J Colorectal Dis (2006) 0.77
Balance between cell division and cell death as predictor of survival in patients with non-small-cell lung cancer. Oncology (2002) 0.77
Evaluation of donor hepatic iron concentration as a factor of early fibrotic progression after liver transplantation. J Hepatol (2004) 0.77
Drug-induced acute cholestatic liver damage in a patient with mutation of UGT1A1. Nat Clin Pract Gastroenterol Hepatol (2007) 0.77
Diagnosis and assessment of Crohn's disease: the present and the future. Expert Rev Gastroenterol Hepatol (2010) 0.77
Cardiac stem cell senescence. Methods Mol Biol (2013) 0.76
Differential proteomic analysis of subfractioned human hepatocellular carcinoma tissues. J Proteome Res (2009) 0.76
PAX8 expression in human bladder cancer. Oncol Rep (2006) 0.76
Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation. World J Gastroenterol (2005) 0.76
Tissue studies in screened first-degree relatives reveal a distinct Crohn's disease phenotype. Inflamm Bowel Dis (2014) 0.75
[Lack of prognostic predictive value of hepatic agobiopsy in a group of patients operated of hepatic resection for hepatocellular carcinoma]. Ann Ital Chir (2010) 0.75
Acetaminophen-induced liver injury in a woman with febrile flare of systemic lupus erythematosus. J Clin Rheumatol (2014) 0.75
Association between vitamin D receptor genetic polymorphisms and acute cellular rejection in liver-transplanted patients. Transpl Int (2012) 0.75
Hepatocellular carcinoma presenting as bile duct tumor: a case report. J Gastrointest Cancer (2014) 0.75
A case report of Sertoli cell tumor in a patient with testicular feminization: many dilemmas for the pathologist. Adv Clin Path (2002) 0.75
Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome. J Gastroenterol (2011) 0.75
[Prevention of post-surgical recurrence of Crohn's disease. A perspective]. Recenti Prog Med (2009) 0.75
Acute severe colitis: infliximab and/or cyclosporine? Curr Drug Targets (2011) 0.75